Материалов:
1 005 012

Репозиториев:
30

Авторов:
596 024

По вашему запросу найдено документов: 54831

Страница 1 из 5484

(1 R,3 S)-3-(1 H -Benzo[ d ]imidazol-2-yl)-1,2,2-tri­methyl­cyclo­pentane-1-carb­oxy­lic acid as a new anti-diabetic active pharmaceutical ingredientThe chiral title compound, C₁₆H₂₀N₂O₂, which can be used for producing active pharmaceutical

Validation of structural-based virtual screening protocols with the PDB Code 3G0B and prediction of the activity of Tinospora crispa compounds as inhibitors of dipeptidyl-peptidase-IVBrotowali (Tinospora crispa) has been traditionally used as an antidiabetic drug. DPP-IV inhibitor

Benzofurocaine: effects on experimental periodontitis, anti-diabetic activity and molecular mechanisms of action: To assess the influence of benzofuracaine on experimental periodontitis and to study its antidiabetic

Antidiabetic Biguanides as Anti-Aging DrugsEvidence has emerged that metformin and other antidiabetic biguabides are promising candidates

Quick Identification of Piperidine Alkaloid from Roots of Grewia nervosa and Their Glucosidase Inhibitory Activity-glucosidase inhibition activity with an IC50 value of 53.40 μm. Furthermore, N-methylmicrocosamine showed maximum α

Course and treatment of diabetes mellitus in the context of COVID-19 of the peculiarities of their immune response to a virus attack and due to their high susceptibility to viral activity

Synthesis, biological activity and molecular modeling of a new series of condensed 1,2,4-triazoles. The compounds showed interesting and promising antidiabetic activities compared to the reference drug Acarbose

Synthesis, α-Glucosidase Inhibitory Activity, and Molecular Docking Studies of Tri(benzo)-5-azacrownophanes with a γ-Piperidone Moiety and they were shown to be potential candidates in the search for new antidiabetic drugs. Among five tested

α-Glucosidase inhibition activity and in silico study of 2-(benzo[d][1,3]dioxol-5-yl)-4H-chromen-4-one, a synthetic derivative of flavone by the one pot reaction method and assessed for α-glucosidase inhibitory activity. The BDC demonstrated dose

(1 R,3 S)-3-(1 H -Benzo[ d ]imidazol-2-yl)-1,2,2-tri­methyl­cyclo­pentane-1-carb­oxy­lic acid as a new anti-diabetic active pharmaceutical ingredientThe chiral title compound, C 16 H 20 N 2 O 2, which can be used for producing active pharmaceutical

Страница 1 из 5484